WikiFX

Rispondi

As an independent trader carefully evaluating brokers, I find DBFS poses several uncertainties, especially when it comes to trading costs for indices like the US100. In my review of DBFS, there is no clear or detailed information about trading fees, spreads, commissions, or overnight financing charges—key components of total trading costs for index products. This absence of transparency makes it impossible for me to accurately calculate or break down the expected costs for trading instruments such as the US100. More crucially, DBFS does not currently offer indices—including the US100—for trading on its platform. Their product list is limited to equities, bonds, mutual funds, futures, and options; forex, indices, commodities, stocks, cryptocurrencies, and ETFs are not available. Even if indices were offered in the future, the fact that DBFS is unregulated and flagged with high risk due to a suspicious regulatory license gives me significant pause. When considering where to trade, understanding and quantifying all costs upfront is vital for risk management and profitability. In my experience, the lack of regulatory oversight combined with limited access to fee and instrument information makes DBFS unsuitable for reliable or informed index trading. For my own capital and peace of mind, I strongly prefer platforms with clear regulatory credentials and full disclosure of trading costs.